State Directory

Provider Records in Indiana

GLP1Search tracks 292 provider records across 61 Indiana cities. 3 records include explicit GLP-1, medication, or peptide treatment evidence; 289 are directory-only healthcare/provider records that need direct confirmation.

Provider Records

292

Cities

61

Treatment Evidence

3

Directory-Only

289

Market Snapshot

Where source-ready GLP-1 records are concentrated in Indiana

The Indiana source-ready local index is led by its largest indexed cities. Across the state, 98% of provider records include phone plus address or website coverage, 0% list public pricing, and 55% carry an upstream source/place signal.

Data Complete

98%

Pricing Visible

0%

Source Flagged

55%

Top Indiana cities for source-ready GLP-1 records

Featured provider records in Indiana

All covered cities in Indiana

Anderson2
Avon3
Bargersville1
Bloomington2
Brazil1
Brownsburg5
Carmel45
Cicero2
Clarksville1
Columbus8
Crawfordsville1
Crown Point7
De Motte1
Dyer2
Elkhart1
Evansville6
Fishers11
Fort Wayne8
Fortville2
Frankfort1
Granger1
Greenfield1
Greenwood10
Hammond1
Highland3
Indianapolis80
Jeffersonville2
Kokomo8
Lafayette6
Manilla1
Marion2
Martinsville1
Merrillville5
Michigantown1
Middlebury1
Mishawaka3
Muncie9
Munster4
New Albany3
New Haven1
New Palestine1
Newburgh1
Noblesville7
Nora1
Pendleton1
Peru1
Plainfield1
Plymouth1
Roanoke2
Schererville1
Seymour1
Shelbyville1
St John2
Syracuse1
Trafalgar1
Valparaiso2
Wabash1
Warsaw2
West Lafayette3
Westfield2
Zionsville6

Questions about provider records in Indiana

How many providers are listed?

GLP1Search lists 292 provider records across 61 cities in Indiana, including 3 treatment-evidence records and 289 directory-only records to verify.

Which cities have the most listings?

Indianapolis (80), Carmel (45), Fishers (11), Greenwood (10), Muncie (9) currently have the highest listing density in Indiana.

What should patients compare?

Compare licensed clinical oversight, medication source, pharmacy type, public pricing, follow-up cadence, side-effect support, and whether the clinic documents semaglutide or tirzepatide availability.